MATHLA: a robust framework for HLA-peptide binding prediction integrating bidirectional LSTM and multiple head attention mechanism.

Journal: BMC bioinformatics
Published Date:

Abstract

BACKGROUND: Accurate prediction of binding between class I human leukocyte antigen (HLA) and neoepitope is critical for target identification within personalized T-cell based immunotherapy. Many recent prediction tools developed upon the deep learning algorithms and mass spectrometry data have indeed showed improvement on the average predicting power for class I HLA-peptide interaction. However, their prediction performances show great variability over individual HLA alleles and peptides with different lengths, which is particularly the case for HLA-C alleles due to the limited amount of experimental data. To meet the increasing demand for attaining the most accurate HLA-peptide binding prediction for individual patient in the real-world clinical studies, more advanced deep learning framework with higher prediction accuracy for HLA-C alleles and longer peptides is highly desirable.

Authors

  • Yilin Ye
    School of Computer Science and Technology, Heilongjiang University, Harbin 150080, China.
  • Jian Wang
    Veterinary Diagnostic Center, Shanghai Animal Disease Control Center, Shanghai, China.
  • Yunwan Xu
    Shenzhen Neocura Biotechnology Co. Ltd., Shenzhen, 518055, China.
  • Yi Wang
    Department of Neurology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
  • Youdong Pan
    Shenzhen Neocura Biotechnology Co. Ltd., Shenzhen, 518055, China.
  • Qi Song
    ‡ College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
  • Xing Liu
    School of Food Science and Engineering, Hainan University 58 Renmin Avenue Haikou 570228 China zhangzeling@hainanu.edu.cn benchao312@hainanu.edu.cn xuhuan.hnu@foxmail.com qichen@hainanu.edu.cn sunzhichang11@163.com hmcao@hainanu.edu.cn.
  • Ji Wan
    Shenzhen Neocura Biotechnology Co. Ltd., Shenzhen, 518055, China. jiw@neocura.net.